mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability
What this study shows
Places mTOR on the RNA polymerase I branch of ribosome building. In HeLa cells, rapamycin (20 or 80 nM for 60 min) almost abolished synthesis of the 45S pre-rRNA precursor while the amounts of Pol I, UBF, TIF-IA and TIF-IB stayed the same, so mTOR acts on the activity of the transcription factor TIF-IA, not on how much machinery the cell has. Rapamycin lowered phosphorylation of TIF-IA at Ser44 and raised it at Ser199, two sites with opposite effects, weakened the TIF-IA interaction with Pol I, and after 2 h shifted TIF-IA out of the nucleus (nuclear TIF-IA roughly halved). Boundary: the authors write that mTOR activates TIF-IA either directly or indirectly, and report as data not shown that immunoprecipitated mTOR and S6K1 did NOT phosphorylate TIF-IA in vitro; Cdk2/cyclin E phosphorylates Ser44, the Ser199 kinase was not identified, and PP2A is proposed as the phosphatase that rapamycin unleashes. The nutrient link rests on a single experiment: nuclear extract from amino-acid-starved cells lost the Ser44 signal in the same way as extract from rapamycin-treated cells. Cell lines only; no animal or human data, and mTORC1 versus mTORC2 was not separated (the complexes were not yet defined in 2004).
At a glance
ShowHide
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mouse FM3A nuclear extracts and NIH3T3 reporter assays; human HeLa and HEK293T cells; rapamycin; in vitro transcription, 2D phosphopeptide mapping, immunofluorescence) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mouse FM3A nuclear extracts and NIH3T3 reporter assays; human HeLa and HEK293T cells; rapamycin; in vitro transcription, 2D phosphopeptide mapping, immunofluorescence |
| Journal | Genes & Development |
| Year | 2004 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.285504 · PMID 15004009 · Free full text (PMC359396) |
Where this study fits
How this study connects to the pathway map, open questions, people and other studies in the Atlas.
Pathway relations
Supports
mTORC1 activates Ribosome biogenesisStrongest evidence: M (Molecular — cells, biochemistry, structure) · emerging, few independent studies · Status: Proposed
plausible in people, not shown directly
Both polymerase branches are in the corpus as of 7 November 2026, and both are indirect: neither paper could show mTOR phosphorylating its target. MAY2004 writes that mTOR activates TIF-IA directly or indirectly and reports that…
People in the Atlas
-
First author of the 2004 Genes & Development study showing that mTOR activates TIF-IA to link rRNA synthesis to nutrients.
-
Last author of the 2004 Genes & Development study showing that mTOR activates TIF-IA to link rRNA synthesis to nutrients.
More: 2 other authors
No profile yet: Zhao J, Yuan X
Related studies
- M mTOR inactivation governs adaptive survival to ribosome biogenesis deficiency
FAN2026 · 2026 · Shares: Ribosome biogenesis
- M TORC1 and PKA activity towards ribosome biogenesis oscillates in synchrony with the budding yeast cell cycle
GUE2022 · 2022 · Shares: Ribosome biogenesis
- M The translational landscape of mTOR signalling steers cancer initiation and metastasis
HSI2012 · 2012 · Shares: Ribosome biogenesis
- M
Topics
Thank you. Your answer was counted anonymously.